Silvestre Vincent

17PUBLICATIONS
166CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer cell biologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 27, 2026
Targeted KRASG12V Degradation in vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.

|Jul 25, 2025
Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy.

Esther Redin, Nerea Otegui, Mirentxu Santos

|Jul 25, 2025
Tumor Organoids Grown in Mixed-Composition Hydrogels Recapitulate the Plasticity of Pancreatic Cancers.

Ioritz Sorzabal-Bellido, Xabier Morales, Iván Cortés-Domínguez

|Jul 15, 2025
To be or not to be (a biliary cancer): RAS (signalling) is the question.

Konstantina Morali, Silvestre Vicent

|Jun 12, 2025
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer.

Borja Ruiz-Fernández de Córdoba, Karmele Valencia, Connor Welch

|Oct 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.

Irati Macaya, Marta Roman, Connor Welch

Pageof 3

Frequent Collaborators

7 joint publications

Elizabeth Guruceaga

5 joint publications

Mariano Ponz-Sarvise

3 joint publications

Juan José Lasarte

3 joint publications

Rodrigo Entrialgo-Cadierno